µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© Thp!X/2O`
>?$qKu
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© BUla2p
1¡¢Co-stimulators (or co-stimulating molecules) \e?w8R.6w^
2¡¢NK-kB *;<oM ]W_
3¡¢Immunoglobulin superfamily E-$N!KY
4¡¢antigen-presenting cell (APC) `g(r.`t^
5¡¢death domain 0"c(n0L
6¡¢CCR and CXCR R%r<AL5kJk
7¡¢Lectin (or mitogen) vnv:YQV/ir
8¡¢Clusters of differentiation, CD) t^<ki?*
9¡¢B7 family (#r>v
h (
10¡¢Cytotoxic T lymphocyte, CTL) )^Md
^\?
11¡¢IL-15 and IL-15 receptor (IL-15R) :x_;-
12¡¢MHC restriction C;eM:v0A[
13¡¢Affinity-chromatography .RWKZB
14¡¢Cyctosprin A, CsA qM
mhmH)Gp
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) (>gHfC>(lq
}!5+G:JAh
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© rY(h }z
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 f\M;m9{(
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
*4{GID
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ pU5t,
FTZaN1%`
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© ^/v!hq_#%&
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ $@4(Lq1.
ѪҺ²¡Ñ§×¨Òµ£º dfA4OZ&
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿